• レポートコード:TPM-2JN013 • 出版社/出版日:Transparency Market Research / 2019年12月30日 • レポート形態:英文、PDF、194ページ • 納品方法:Eメール • 産業分類:医療機器 |
Single User | ¥846,070 (USD5,795) | ▷ お問い合わせ |
Multi User | ¥1,284,070 (USD8,795) | ▷ お問い合わせ |
Corporate License | ¥1,722,070 (USD11,795) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートは呼吸監視装置の世界市場について調査・分析し、序論、仮定・研究方法、エグゼクティブサマリー、市場状況、市場動向、製品別分析、エンドユーザ別分析、地域別(北米、欧州、アジア太平洋、中南米、中東・アフリカ)分析、競争状況などを含め、次の構成でお届けいたします。 ・序論 ・仮定・研究方法 ・エグゼクティブサマリー ・市場状況 ・市場動向 ・呼吸監視装置の世界市場:製品別 ・呼吸監視装置の世界市場:エンドユーザ別 ・呼吸監視装置の世界市場:地域別(北米、欧州、アジア太平洋、中南米、中東・アフリカ) ・呼吸監視装置の北米市場分析・予測 ・呼吸監視装置の欧州市場分析・予測 ・呼吸監視装置のアジア太平洋市場分析・予測 ・呼吸監視装置の中南米市場分析・予測 ・呼吸監視装置の中東・アフリカ市場分析・予測 ・競争状況 |
High prevalence of asthma and chronic obstructive pulmonary diseases (COPDs) are some of the major factors driving the demand for respiratory monitoring devices. Hence, manufacturers in the respiratory monitoring devices market are innovating in wearable strain sensors for effective management of chronic respiratory diseases (CRDs). They are increasing efforts to introduce wearable sensors capable of providing measurements on respiration rate (RR) as well as volume with high fidelity. In order to offer more convenience to patients, manufacturers are increasing their production capabilities of disposable wearable sensors.
Companies in the respiratory monitoring devices market landscape are increasing R&D activities to develop wearable sensors that are capable of detecting respiration under various ambulatory conditions. These sensors are built on the technology of medical grade continuous spirometers. As such, spirometers record third-highest revenue in the respiratory monitoring devices market. The spirometers product segment is expected to reach value of ~US$ 1.1 Bn by the end of 2027. Hence, manufacturers are innovating in the spirometry technology for the development of innovative wearable sensors.
Polysomnography (PSG) is considered as the gold standard to receive data on respiration and sleep patterns. Companies in the respiratory monitoring devices market are increasing their efforts to develop PSG sensors that provide a wealth of information to healthcare providers. Though methods of automatic analysis are available in the healthcare industry, skilled technicians typically opt for PSG. Signal analysis and machine learning are key factors boosting the adoption of PSG in the healthcare industry. Manufacturers are increasing their research efforts in the two domains to help healthcare providers capture complex information and patterns of patients.
Moreover, new parameters for diagnosis and symptom severity are fueling the adoption of signal analysis and machine learning to enhance the outcomes via PSG. Companies in the respiratory monitoring devices market are introducing the technology of automatic detection in PSG to assess sleep-related breathing events of patients. They are making available conventional PSG sensors and new devices to identify pathological phenomena of sleep-related breathing events. Manufacturers are taking the help of well-characterized datasets to validate new algorithms related to respiratory diseases.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Respiratory Monitoring Devices Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Respiratory Monitoring Devices Market Analysis and Forecast, 2017–2027
5. Market Outlook
5.1. Technological Advancements
5.2. Prevalence of Asthma & COPD by Region/ Country
5.3. Annual Cost of COPD and Asthma
5.4. Key Industry Events (Mergers, Acquisitions, Collaborations, Launch & Approvals, etc)
5.5. Reimbursement Scenario
5.6. Overview of respiratory disease monitoring in homecare settings
6. Global Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Product
6.1. Introduction & Definition
6.2. Global Respiratory Monitoring Devices Market Value Forecast, by Product, 2017–2027
6.2.1. Pulse Oximeters
6.2.2. Capnographs
6.2.3. Spirometers
6.2.4. Polysomnographs (PSG)
6.2.5. Peak Flow Meters
6.2.6. Gas Analyzers
6.2.7. Others
6.3. Global Respiratory Monitoring Devices Market Attractiveness, by Product
7. Global Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by End User
7.1. Introduction
7.2. Global Respiratory Monitoring Devices Market Value Forecast, by End User, 2017–2027
7.2.1. Home care
7.2.2. Hospitals
7.2.3. Ambulatory Surgical Centers
7.2.4. Specialty Clinics
7.3. Global Respiratory Monitoring Devices Market Attractiveness, by End User
8. Global Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Region
8.1. Introduction
8.2. Global Respiratory Monitoring Devices Market Value Forecast, by Region, 2017–2027
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Global Respiratory Monitoring Devices Market Attractiveness, by Region
9. North America Respiratory Monitoring Devices Market Analysis and Forecast
9.1. Introduction
9.2. North America Respiratory Monitoring Devices Market Value Forecast, by Product, 2017–2027
9.2.1. Pulse Oximeters
9.2.2. Capnographs
9.2.3. Spirometers
9.2.4. Polysomnographs (PSG)
9.2.5. Peak Flow Meters
9.2.6. Gas Analyzers
9.2.7. Others
9.3. North America Respiratory Monitoring Devices Market Value Forecast, by End User, 2017–2027
9.3.1. Home care
9.3.2. Hospitals
9.3.3. Ambulatory Surgical Centers
9.3.4. Specialty Clinics
9.4. North America Respiratory Monitoring Devices Market Value Forecast, by Country/Sub-region, 2017–2027
9.4.1. U.S.
9.4.2. Canada
9.5. North America Respiratory Monitoring Devices Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By End User
9.5.3. By Country/Sub-region
10. Europe Respiratory Monitoring Devices Market Analysis and Forecast
10.1. Introduction
10.2. Europe Respiratory Monitoring Devices Market Value Forecast, by Product, 2017–2027
10.2.1. Pulse Oximeters
10.2.2. Capnographs
10.2.3. Spirometers
10.2.4. Polysomnographs (PSG)
10.2.5. Peak Flow Meters
10.2.6. Gas Analyzers
10.2.7. Others
10.3. Europe Respiratory Monitoring Devices Market Value Forecast, by End User, 2017–2027
10.3.1. Home care
10.3.2. Hospitals
10.3.3. Ambulatory Surgical Centers
10.3.4. Specialty Clinics
10.4. Europe Respiratory Monitoring Devices Market Value Forecast, by Country/Sub-region, 2017–2027
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe Respiratory Monitoring Devices Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By End User
10.5.3. By Country/Sub-region
11. Asia Pacific Respiratory Monitoring Devices Market Analysis and Forecast
11.1. Introduction
11.2. Asia Pacific Respiratory Monitoring Devices Market Value Forecast, by Product, 2017–2027
11.2.1. Pulse Oximeters
11.2.2. Capnographs
11.2.3. Spirometers
11.2.4. Polysomnographs (PSG)
11.2.5. Peak Flow Meters
11.2.6. Gas Analyzers
11.2.7. Others
11.3. Asia Pacific Respiratory Monitoring Devices Market Value Forecast, by End User, 2017–2027
11.3.1. Home care
11.3.2. Hospitals
11.3.3. Ambulatory Surgical Centers
11.3.4. Specialty Clinics
11.4. Asia Pacific Respiratory Monitoring Devices Market Value Forecast, by Country/Sub-region, 2017–2027
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Asia Pacific Respiratory Monitoring Devices Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By End User
11.5.3. By Country/Sub-region
12. Latin America Respiratory Monitoring Devices Market Analysis and Forecast
12.1. Introduction
12.2. Latin America Respiratory Monitoring Devices Market Value Forecast, by Product, 2017–2027
12.2.1. Pulse Oximeters
12.2.2. Capnographs
12.2.3. Spirometers
12.2.4. Polysomnographs (PSG)
12.2.5. Peak Flow Meters
12.2.6. Gas Analyzers
12.2.7. Others
12.3. Latin America Respiratory Monitoring Devices Market Value Forecast, by End User, 2017–2027
12.3.1. Home care
12.3.2. Hospitals
12.3.3. Ambulatory Surgical Centers
12.3.4. Specialty Clinics
12.4. Latin America Respiratory Monitoring Devices Market Value Forecast, by Country/Sub-region, 2017–2027
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Latin America Respiratory Monitoring Devices Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By End User
12.5.3. By Country/Sub-region
13. Middle East & Africa Respiratory Monitoring Devices Market Analysis and Forecast
13.1. Introduction
13.2. Middle East & Africa Respiratory Monitoring Devices Market Value Forecast, by Product, 2017–2027
13.2.1. Pulse Oximeters
13.2.2. Capnographs
13.2.3. Spirometers
13.2.4. Polysomnographs (PSG)
13.2.5. Peak Flow Meters
13.2.6. Gas Analyzers
13.2.7. Others
13.3. Middle East & Africa Respiratory Monitoring Devices Market Value Forecast, by End User, 2017–2027
13.3.1. Home care
13.3.2. Hospitals
13.3.3. Ambulatory Surgical Centers
13.3.4. Specialty Clinics
13.3.5. Hospitals
13.4. Middle East & Africa Respiratory Monitoring Devices Market Value Forecast, by Country/Sub-region, 2017–2027
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Middle East & Africa Respiratory Monitoring Devices Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By End User
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Global Respiratory Monitoring Devices Market Share Analysis, by Company (2018)
14.2. Company Profiles
14.2.1. Medtronic
14.2.1.1. Company Description
14.2.1.2. Business Overview
14.2.1.3. Financial Overview
14.2.1.4. Strategic Overview
14.2.1.5. SWOT Analysis
14.2.2. Philips Healthcare (Koninklijke Philips N.V.)
14.2.2.1. Company Description
14.2.2.2. Business Overview
14.2.2.3. Financial Overview
14.2.2.4. Strategic Overview
14.2.2.5. SWOT Analysis
14.2.3. Smiths Medical (part of Smiths Group plc)
14.2.3.1. Company Description
14.2.3.2. Business Overview
14.2.3.3. Financial Overview
14.2.3.4. Strategic Overview
14.2.3.5. SWOT Analysis
14.2.4. Dragerwerk AG & Co. KGaA
14.2.4.1. Company Description
14.2.4.2. Business Overview
14.2.4.3. Financial Overview
14.2.4.4. Strategic Overview
14.2.4.5. SWOT Analysis
14.2.5. GE Healthcare (part of General Electric Company)
14.2.5.1. Company Description
14.2.5.2. Business Overview
14.2.5.3. Financial Overview
14.2.5.4. Strategic Overview
14.2.5.5. SWOT Analysis
14.2.6. Welch Allyn, Inc. (Hill-Rom Holdings, Inc.)
14.2.6.1. Company Description
14.2.6.2. Business Overview
14.2.6.3. Financial Overview
14.2.6.4. Strategic Overview
14.2.6.5. SWOT Analysis
14.2.7. Masimo
14.2.7.1. Company Description
14.2.7.2. Business Overview
14.2.7.3. Financial Overview
14.2.7.4. Strategic Overview
14.2.7.5. SWOT Analysis
14.2.8. MGC Diagnostics Corporation
14.2.8.1. Company Description
14.2.8.2. Business Overview
14.2.8.3. SWOT Analysis
14.2.9. Vyaire Medical Inc. (Becton, Dickinson and Company and Apax Partners’ Joint Venture)
14.2.9.1. Company Description
14.2.9.2. Business Overview
14.2.9.3. Strategic Overview
14.2.9.4. SWOT Analysis
14.2.10. Nihon Kohden Corporation
14.2.10.1. Company Description
14.2.10.2. Business Overview
14.2.10.3. Financial Overview
14.2.10.4. Strategic Overview
14.2.10.5. SWOT Analysis
14.2.11. Novelda AS
14.2.11.1. Company Description
14.2.11.2. Business Overview
14.2.11.3. Strategic Overview
14.2.11.4. SWOT Analysis
List of FiguresFigure 01: Global Respiratory Monitoring Devices Size ($ Million) and Distribution by Geography, 2018 and 2027
Figure 02: Global Respiratory Monitoring Devices, by Region (2018)
Figure 03: Global Respiratory Monitoring Devices Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 04: Market Value Share by Product (%), 2018
Figure 05: Market Value Share by End User (%), 2018
Figure 06: Market Value Share by Geography (%), 2018
Figure 07: Global Respiratory Monitoring Devices Market Value Share, by Product, 2018 and 2027
Figure 08: Global Respiratory Monitoring Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Pulse Oximeters, 2017–2027
Figure 09: Global Respiratory Monitoring Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Capnographs, 2017–2027
Figure 10: Global Respiratory Monitoring Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Spirometers, 2017–2027
Figure 11: Global Respiratory Monitoring Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Polysomnographs (PSG), 2017–2027
Figure 12: Global Respiratory Monitoring Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Peak Flow Meters, 2017–2027
Figure 13: Global Respiratory Monitoring Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Gas Analyzers, 2017–2027
Figure 14: Global Respiratory Monitoring Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027
Figure 15: Global Respiratory Monitoring Devices Market Attractiveness Analysis, by Product, 2019-2027
Figure 16: Global Respiratory Monitoring Devices Market Value Share, by End User, 2018 and 2027
Figure 17: Global Respiratory Monitoring Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Home Care, 2017–2027
Figure 18: Global Respiratory Monitoring Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017–2027
Figure 19: Global Respiratory Monitoring Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Ambulatory Surgical Centers, 2017–2027
Figure 20: Global Respiratory Monitoring Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Specialty Clinics, 2017–2027
Figure 21: Global Respiratory Monitoring Devices Market Attractiveness Analysis, by End User, 2019-2027
Figure 22: Global Respiratory Monitoring Devices Market Value Share, by Region, 2018 and 2027
Figure 23: Global Respiratory Monitoring Devices Market Attractiveness Analysis, by Region, 2019-2027
Figure 24: North America Respiratory Monitoring Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 25: North America Respiratory Monitoring Devices Market Share Analysis, by Product, 2018 and 2027
Figure 26: North America Respiratory Monitoring Devices Market Attractiveness Analysis, by Product, 2019–2027
Figure 27: North America Respiratory Monitoring Devices Market Share Analysis, by End User, 2018 and 2027
Figure 28: North America Respiratory Monitoring Devices Market Attractiveness Analysis, by End User, 2019–2027
Figure 29: North America Respiratory Monitoring Devices Market Value Share Analysis, by Country, 2018 and 2027
Figure 30: North America Respiratory Monitoring Devices Market Attractiveness Analysis, by Country, 2019–2027
Figure 31: Europe Respiratory Monitoring Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 32: Europe Respiratory Monitoring Devices Market Share Analysis, by Product, 2018 and 2027
Figure 33: Europe Respiratory Monitoring Devices Market Attractiveness Analysis, by Product, 2019–2027
Figure 34: Europe Respiratory Monitoring Devices Market Share Analysis, by End User, 2018 and 2027
Figure 35: Europe Respiratory Monitoring Devices Market Attractiveness Analysis, by End User, 2019-2027
Figure 36: Europe Respiratory Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 37: Europe Respiratory Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 38: Asia Pacific Respiratory Monitoring Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 39: Asia Pacific Respiratory Monitoring Devices Market Share Analysis, by Product, 2018 and 2027
Figure 40: Asia Pacific Respiratory Monitoring Devices Market Attractiveness Analysis, by Product, 2019–2027
Figure 41: Asia Pacific Respiratory Monitoring Devices Market Share Analysis, by End User, 2018 and 2027
Figure 42: Asia Pacific Respiratory Monitoring Devices Market Attractiveness Analysis, by End User, 2019–2027
Figure 43: Asia Pacific Respiratory Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 44: Asia Pacific Respiratory Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 45: Latin America Respiratory Monitoring Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 46: Latin America Respiratory Monitoring Devices Market Share Analysis, by Product, 2018 and 2027
Figure 47: Latin America Respiratory Monitoring Devices Market Attractiveness Analysis, by Product, 2019–2027
Figure 48: Latin America Respiratory Monitoring Devices Market Share Analysis, by End User, 2018 and 2027
Figure 49: Latin America Respiratory Monitoring Devices Market Attractiveness Analysis, by End User, 2019–2027
Figure 50: Latin America Respiratory Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 51: Latin America Respiratory Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 52: Middle East & Africa Respiratory Monitoring Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 53: Middle East & Africa Respiratory Monitoring Devices Market Share Analysis, by Product, 2018 and 2027
Figure 54: Middle East & Africa Respiratory Monitoring Devices Market Attractiveness Analysis, by Product
Figure 55: Middle East & Africa Respiratory Monitoring Devices Market Share Analysis, by End User, 2018 and 2027
Figure 56: Middle East & Africa Respiratory Monitoring Devices Market Attractiveness Analysis, by End User, 2019-2027
Figure 57: Middle East & Africa Respiratory Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 58: Middle East & Africa Respiratory Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 59: Global Respiratory Monitoring Devices Market Share Analysis, by Company (2017)
Figure 60: Medtronic Respiratory, Gastrointestinal, & Renal Division Revenue (US$ Mn) and Y-o-Y Growth (%), 2016-2018
Figure 61: Medtronic Breakdown of Net Sales (%) of Minimally Invasive Therapies Group, by Region, 2018
Figure 62: Medtronic Minimally Invasive Therapies Group Segment Breakdown of Net Sales (%), by Division, 2018
Figure 63: Medtronic R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2018
Figure 64: Philips Group Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2018
Figure 65: Philips Group Breakdown of Net Sales (%), by Region, 2018
Figure 66: Philips Group R&D Expenditure (US$ Mn) and Y-o-Y Growth (%), 2016–2018
Figure 67: Philips Group Breakdown of Net Sales (%), by Business Segment, 2018
Figure 68: Smiths Medical Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2019
Figure 69: Smiths Group plc Breakdown of Net Sales (%), by Region, 2019
Figure 70: Smiths Group plc R&D Expenditure (US$ Mn) and Y-o-Y Growth (%), 2017–2019
Figure 71: Smiths Medical Breakdown of Net Sales (%), by Sector, 2019
Figure 72: Dragerwerk AG & Co. KGaA (Medical Group) Revenue (US$ Mn), 2016–2018
Figure 73: Dragerwerk AG & Co. KGaA Breakdown of Net Sales (%), by Region, 2018
Figure 74: Dragerwerk AG & Co. KGaA R&D Expenditure (US$ Mn) and Y-o-Y Growth (%), 2016–2018
Figure 75: Dragerwerk AG & Co. KGaA Breakdown of Net Sales (%), by Business Segment, 2018
Figure 76: GE Healthcare Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2018
Figure 77: GE Healthcare Breakdown of Healthcare Business Segment Net Sales (%), by Region, 2018
Figure 78: GE Healthcare R&D Expenditure (US$ Mn) and Y-o-Y Growth (%),
Figure 79: GE Healthcare Breakdown of Net Sales (%), by Healthcare Sub-Segment, 2018
Figure 80: Hill-Rom Holdings, Inc. Revenue, (US$ Mn) and Y-o-Y Growth (%), 2016–2018
Figure 81: Hill-Rom Holdings, Inc., Breakdown of Net Sales (%), by Geography, 2018
Figure 82: Hill-Rom Holdings, Inc., Breakdown of Net Sales (%), by Business Segment, 2018
Figure 83: Hill-Rom Holdings, Inc., R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2018
Figure 84: Masimo Revenue, (US$ Mn) and Y-o-Y Growth (%), 2016–2018
Figure 85: Masimo Breakdown of Net Sales (%), by Geography, 2018
Figure 86: Masimo R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2018
Figure 87: Nihon Kohden Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2018
Figure 88: Nihon Kohden Corporation Breakdown of Net Sales (%), by Product, 2018
Figure 89: Nihon Kohden Corporation R&D Expenditure (US$ Mn) and Y-o-Y Growth (%),
Figure 90: Nihon Kohden Corporation Breakdown of Healthcare Business Segment Net Sales (%), by Region, 2018